Veterinary Intravenous (IV) Solutions Market to Grow with a CAGR of 6.57% through 2030F
Rising
pet ownership and the increasing surge of veterinary specialization are factors
driving the global veterinary intravenous (iv) solutions market in the forecast
period 2026-2030F
According to TechSci Research report, “Veterinary
Intravenous (IV) Solutions Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030F”, the Global
Veterinary Intravenous (IV) Solutions Market stood at USD 1.35 billion in 2024 and is anticipated to grow with a CAGR of 6.57% in the forecast period,
2026-2030. Veterinary medicine has evolved from a generalized practice to a
field with specialized areas such as cardiology, oncology, and dermatology.
These specializations demand targeted treatments, including IV therapies, to
address specific health concerns. The development of specialized treatments has
expanded the market for veterinary IV solutions.
The livestock and production animal
sectors play a critical role in the global food supply. As demand for
animal-based products continues to rise, farmers and producers are recognizing
the need for better healthcare solutions to ensure the health and productivity
of their animals. Veterinary IV solutions are becoming essential tools in
managing the health of livestock and production animals. Just like humans, pets
are also experiencing an increase in life expectancy due to better healthcare
practices and improved living conditions. However, with age comes a higher
likelihood of health issues that require medical interventions, including IV
therapies. The aging pet population is contributing to the sustained demand for
veterinary IV solutions.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on
"Global Veterinary Intravenous (IV)
Solutions Market.”
Rapid urbanization and changing
lifestyles have led to smaller living spaces and limited outdoor access for
pets. This often translates to increased health risks, making timely and
effective medical interventions crucial. Veterinary IV solutions offer a reliable
method of delivering medications and fluids to address various health
conditions.
The phenomenon of pet humanization has
taken the world by storm. As more households consider their pets as integral
members of the family, the demand for advanced healthcare services has
increased substantially. Pet owners are more willing to invest in treatments
that ensure the health and well-being of their furry companions, including
intravenous therapies.
Just as in human medicine, technological
advancements are revolutionizing veterinary care. Newer and more efficient IV
delivery systems, better monitoring tools, and improved diagnostic techniques
are making IV solutions safer and more effective for animals. These
technological innovations are driving the adoption of veterinary IV solutions
across the globe.
Regulatory bodies across the globe are
becoming more focused on ensuring the safety and efficacy of veterinary
products, including IV solutions. This increasing scrutiny and regulation
provide a conducive environment for the development and commercialization of
high-quality veterinary IV solutions.
The Global Veterinary
Intravenous (IV) Solutions Market is segmented into product, animal type,
indication, end use and company.
Based on product, the
isotonic crystalloids segment has emerged as the predominant market leader. In
the rapidly evolving landscape of veterinary medicine, isotonic crystalloids
have emerged as a dominant force in the global veterinary IV solutions market.
Their compatibility with physiology, versatility, electrolyte-balancing
capabilities, suitability for emergency care, and minimal side effects position
them as a trusted choice for veterinarians worldwide. As the demand for
advanced veterinary care continues to rise, isotonic crystalloids are likely to
maintain their stronghold in the market, contributing significantly to the
well-being and health of our beloved animal companions. Isotonic crystalloids
generally have few side effects, making them safer for use in a variety of
animal species. This safety profile contributes to their popularity among
veterinarians. In emergency situations, quick fluid resuscitation is often
essential to stabilize patients. Isotonic crystalloids' ability to swiftly
restore blood volume and circulatory stability makes them a frontline choice in
critical care scenarios.
Based on region, the Asia Pacific region
is experiencing rapid market growth. Apart from companion animals, Asia Pacific
also holds a substantial livestock industry. The increasing demand for safe and
efficient veterinary healthcare solutions in livestock production has contributed
significantly to the dominance of North America in the veterinary IV solutions
market. Farmers and ranchers prioritize animal health and invest in
high-quality medical interventions to ensure the productivity and welfare of
their livestock.
Major companies
operating in Global Veterinary Intravenous (IV) Solutions Market are:
·
Merck
& Co., Inc.
·
Dechra
Veterinary Products
·
Sypharma
Pty Ltd.
·
Animalcare
group plc
·
Braun
SE
·
Woods
Consulting, LLC
·
Baxter
International
·
Fresenius
Kabi
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“Veterinary IV solutions have
revolutionized the way animals receive medical care, providing essential fluids
and medications with precision and efficiency. The global trends in this field
indicate a shift toward specialization, technological integration, and
nutritional support. While challenges such as access and cost persist, the
ongoing advancements and future prospects paint a promising picture for the
field of veterinary IV solutions. As these innovations continue to evolve, the
quality of care for animals around the world is expected to improve,
solidifying the crucial role of IV solutions in the realm of veterinary
medicine.,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Veterinary Intravenous (IV)
Solutions Market, By Product (Isotonic crystalloids, Synthetic colloids,
Blood products, Dextrose solutions, Parenteral nutrition), By Indication
(Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others),
By Animal type ( Companion Animals, Production Animals), By End Use (
Veterinary Hospitals, Research Institutes, Others), By Region, By
Competition Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of Global Veterinary Intravenous (IV) Solutions
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Veterinary
Intravenous (IV) Solutions Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com